Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-25 4:58 pm Purchase |
2023-05-23 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 1,944,455 23.800% |
80,000 (+4.29%) |
Filing History |
| 2023-05-18 4:32 pm Purchase |
2023-05-11 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 1,864,455 22.800% |
1,864,455 (New Position) |
Filing History |
| 2023-05-15 5:02 pm Purchase |
2023-05-08 | 13G | Soleno Therapeutics, Inc. SLNO |
Vivo Opportunity Fund Holdings, L.P. | 8,418,093 19.990% |
8,418,093 (New Position) |
Filing History |
| 2023-05-10 4:32 pm Unchanged |
2023-05-08 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-15 07:26 am Sale |
2022-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
HIRSCHMAN ORIN | 422,489 5.200% |
-30,844 (-6.80%) |
Filing History |
| 2023-02-14 5:06 pm Purchase |
2022-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
Nantahala Capital Management, LLC | 838,534 9.900% |
187,525 (+28.81%) |
Filing History |
| 2022-12-20 4:30 pm Sale |
2022-12-16 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
0 0.000% |
-1,224,571 (Position Closed) |
Filing History |
| 2022-08-11 4:56 pm Purchase |
2022-08-01 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
1,224,571 15.300% |
1,224,571 (New Position) |
Filing History |
| 2022-04-08 4:35 pm Purchase |
2022-03-29 | 13D | Soleno Therapeutics, Inc. SLNO |
Abingworth LLP | 1,224,558 15.300% |
521,598 (+74.20%) |
Filing History |
| 2022-04-05 4:01 pm Sale |
2021-02-18 | 13D | Soleno Therapeutics, Inc. SLNO |
Jack W. Schuler Living Trust | 794,120 9.600% |
-48,878 (-5.80%) |
Filing History |
| 2022-04-05 08:05 am Purchase |
2022-03-29 | 13G | Soleno Therapeutics, Inc. SLNO |
HIRSCHMAN ORIN | 453,333 5.700% |
453,333 (New Position) |
Filing History |
| 2022-02-14 08:22 am Unchanged |
2021-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
Nantahala Capital Management, LLC | 651,009 12.200% |
0 (Unchanged) |
Filing History |
| 2022-02-11 4:55 pm Sale |
2021-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% |
-383,880 (Position Closed) |
Filing History |
| 2021-07-12 4:01 pm Purchase |
2021-06-30 | 13G | Soleno Therapeutics, Inc. SLNO |
Nantahala Capital Management, LLC | 651,009 12.200% |
126,252 (+24.06%) |
Filing History |
| 2021-02-16 4:02 pm Sale |
2020-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
FEINBERG LARRY N | 248,843 4.700% |
-131,160 (-34.52%) |
Filing History |
| 2021-02-12 3:22 pm Purchase |
2020-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
Nantahala Capital Management, LLC | 524,757 9.900% |
239,562 (+84.00%) |
Filing History |
| 2020-11-09 4:46 pm Purchase |
2020-10-30 | 13G | Soleno Therapeutics, Inc. SLNO |
SUVRETTA CAPITAL MANAGEMENT, LLC | 383,880 7.200% |
383,880 (New Position) |
Filing History |
| 2020-07-16 7:10 pm Purchase |
2019-03-21 | 13D | Soleno Therapeutics, Inc. SLNO |
Jack W. Schuler Living Trust | 842,998 15.650% |
666,716 (+378.21%) |
Filing History |
| 2020-07-06 4:00 pm Purchase |
2020-06-26 | 13D | Soleno Therapeutics, Inc. SLNO |
Abingworth LLP | 702,960 13.200% |
376,055 (+115.04%) |
Filing History |
| 2020-06-11 5:00 pm Sale |
2020-06-09 | 13D | Soleno Therapeutics, Inc. SLNO |
Vivo Ventures V LLC | 55,742 1.800% |
-146,150 (-72.39%) |
Filing History |